- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/135 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Patent holdings for IPC class C07D 295/135
Total number of patents in this class: 422
10-year publication summary
|
33
|
22
|
23
|
27
|
29
|
24
|
22
|
22
|
18
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Richter Gedeon Nyrt. | 1635 |
15 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3166 |
13 |
| Gen1e Lifesciences Inc. | 25 |
9 |
| ChemoCentryx, Inc. | 386 |
8 |
| PIMCO 2664 Limited | 20 |
7 |
| The Regents of the University of California | 19961 |
6 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2165 |
6 |
| The United States Government AS represented by The Department of Veterans Affairs | 1191 |
6 |
| The United States of America as represented by the Department of Veterans Affairs | 300 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
5 |
| Neoculi Pty Ltd | 18 |
5 |
| AstraZeneca AB | 2892 |
4 |
| AbbVie Deutschland GmbH & Co. KG | 261 |
4 |
| Curza Global, LLC | 29 |
4 |
| Omeros Corporation | 306 |
4 |
| University of Utah Research Foundation | 1810 |
4 |
| Lunella Biotech, Inc. | 104 |
4 |
| Merck Sharp & Dohme LLC | 3751 |
4 |
| Glaxo Group Limited | 4063 |
3 |
| Hoffmann-La Roche Inc. | 3439 |
3 |
| Other owners | 302 |